Jump to content
Sclero Forums

Search the Community

Showing results for tags 'rheumatoid arthritis'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Worldwide
    • Welcome: Guidelines and FAQs
    • Sclero Forums (MAIN)
    • UK Scleroderma
    • News
    • Personal Support

Blogs

  • CFM Babs from Chorley FM
  • barefut impressions
  • My Two Cents...
  • Amanda Thorpe's Blog
  • Joelf's Blog
  • Michael Thorpe's Blog

Found 20 results

  1. Risk of incident liver disease in patients with psoriasis (PsO), psoriatic arthritis (PsA) and rheumatoid arthritis (RA): a population–based study. More so than RA, PsO and PsA are associated with liver disease, particularly non-alcoholic fatty liver disease and cirrhosis, and this was true even among patients without systemic therapy exposure. PubMed, J Invest Dermatol, 10/27/2017. (Also see Psoriasis and Psoriatic Arthritis and Symptoms and Complications of Rheumatoid Arthritis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  2. Serum serotonin levels and bone in rheumatoid arthritis (RA) patients. Our data reinforce a role, despite weak, for circulating serotonin in regulating bone mass in RA patients, with some differences in terms of gender and anatomical sites. PubMed, Rheumatol Int, 10/09/2017. (Also see Symptoms and Complications of Rheumatoid Arthritis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  3. Discrepancy between subjective and objective measures of cognitive impairment in patients with rheumatoid arthritis. The findings emphasize the gap between subjective and objective measures of cognitive impairment and the importance of considering psychological factors within the context of cognitive complaints in clinical settings. PubMed, Rheumatol Int, 09/04/2017. (Also see Symptoms and Complications of Rheumatoid Arthritis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  4. Gut bacteria linked to Rheumatoid Arthritis Rheumatoid arthritis has confounded efforts to identify its trigger and mounting evidence points to a new suspect: a disturbance in the bacteria that live in the intestines. NIH Research Matters, 11/25/2013. (Also see: Rheumatoid Arthritis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  5. There is still a care gap in osteoporosis management for patients with rheumatoid arthritis. Although compliance with current osteoporosis guidelines remains low among all patients with rheumatoid arthritis, higher risk patients were more likely to have a bone mineral density test and receive treatment for osteoporosis. PubMed, Joint Bone Spine, 2014 Apr 2. (Also see: Rheumatoid Arthritis and Osteoporosis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  6. Pain in rheumatoid arthritis: a critical review. The management of pain requires various approaches that include pharmacological analgesia and biological and non-biological treatments and although joint replacement surgery can significantly improve RA-related pain, it may only be available to patients with the most severe advanced disease. PubMed, Reumatismo, 2014 Jun 6;66(1):18-27. (Also see: Rheumatoid Arthritis and Pain Management) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  7. Functional Impact of a Spectrum of Interstitial Lung Abnormalities (ILAs) in Rheumatoid Arthritis (RA). Improved risk stratification and detection of ILAs will provide a therapeutic window that could improve RA-ILD (interstitial lung disease) outcomes. CHEST Journal 2014;146(1):41-50. (Also see: Rheumatoid Arthritis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  8. Immune responses to stress in rheumatoid arthritis (RA) and psoriasis. Patients with RA have a different immune response to stress than patients with psoriasis or healthy controls. More needs to be learned about the complex interaction between stress, immune parameters and chronic inflammation. PubMed, Rheumatology (Oxford), 2014 May 20. (Also see: Rheumatoid Arthritis, Psoriasis, and Stress) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  9. Low vitamin D level is not associated with increased incidence of rheumatoid arthritis (RA). Vitamin D levels were not associated with the development of RA in this patient population with matched controls. PubMed, Rheumatol Int. 2014 Apr 19. (Also see: Rheumatoid Arthritis and Autoimmune Diseases and Vitamin D) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  10. Structural deterioration of finger joints with ultrasonographic synovitis in rheumatoid arthritis patients with clinical low disease activity (CLDA). Even in patients with a long period of CLDA, finger joints with positive synovial vascularity showed structural alteration, especially in the progression of joint space narrowing. PubMed, Rheumatology (Oxford), 2014 Apr 4. (Also see: Symptoms of Rheumatoid Arthritis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  11. Depression and pain in patients with rheumatoid arthritis (RA): Mediating role of illness perception. Targeting illness perceptions in adults with RA and depression may help reduce pain symptoms. ScienceDirect, The Egyptian Rheumatologist, April 2014. (Also see: Rheumatoid Arthritis and Depression) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  12. Pathogenesis and prevention of rheumatic disease: focus on preclinical rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). This review focuses on the preclinical stages of RA and SLE, as our current understanding of these diseases can be used to present an overall model of the development of autoimmune rheumatic diseases that might ultimately be used to develop screening programmes and preventive strategies. PubMed, Nat Rev Rheumatol. 2014 Feb 11. (Also see: Systemic Lupus Erythematosus Causes and Rheumatoid Arthritis Causes) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  13. Mesenchymal Stem Cells (MSC), Autoimmunity & Rheumatoid Arthritis. A better understanding of the link between these cells and their biology could be a key to developing novel MSC based strategies for therapy. PubMed, QJM. 2014 Feb 10. (Also see: Rheumatoid Arthritis Causes and Autoimmunity) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  14. Rheuminations: New RA Antibody Coming Soon? Patients with rheumatoid arthritis (RA) who don't do well with the available biologic therapies may soon have another therapeutic option: monoclonal antibodies that target granulocyte-macrophage colony-stimulating factor (GM-CSF). MedPage Today, 02/20/2014. (Also see: Rheumatoid Arthritis Treatments) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  15. Mayo Study Finds Shoulder Replacement Eases Pain, Improves Motion in Rheumatoid Arthritis Patients. Despite surgical challenges with some rheumatoid arthritis patients, the procedure improves range of motion and reduces pain in nearly all cases, especially for those with intact rotator cuffs. Mayo Clinic News Network, 01/13/2014. (Also see: Rheumatoid Arthritis Treatments) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  16. Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis (RA). One of the subjective components of the DAS28, patient VAS, was highly correlated with cognitive factors and depression in those with severe RA. Wiley Online Library, 12/13/2013. (Also see: Rheumatoid Arthritis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  17. Sleep Problems in Patients with Rheumatoid Arthritis (RA). Poor control of RA is associated with a reduction in sleep quality and decreased daytime sleepiness, which is likely explained by pain-related alertness. PubMed, J Rheumatol, 2013 Dec 1. (Also see: Rheumatoid Arthritis, and Sleep Disorders and Illness) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  18. Patients with the most advanced rheumatoid arthritis (RA) remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement. Although therapy induced clinical improvement in almost all patients, those with advanced RA remained with signs of inflammation. PubMed, 2013 No Rheumatol Int. v13. (Also see: Rheumatoid Arthritis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  19. Emerging cell and cytokine targets in rheumatoid arthritis. These exciting new approaches will considerably enhance our repertoire in the battle against this potentially devastating disease. PubMed, Nat Rev Rheumatol, 2013 Nov 12. (Also see: Rheumatoid Arthritis Treatments) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  20. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs(sDMARDs and bDMARDs): 2013 update. EULAR's most recent consensus on the management of RA with sDMARDs, glucocorticoids and bDMARDs. PubMed, Ann rheumatologist Dis, 2013 Oct 25. (Also see: Rheumatoid Arthritis Treatments and DMARDs) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
×